Replies to post #104832 on Biotech Values

[pollyvonwog]

People should have listened to him and not Dew. They would have been much better off.

Wallstar claimed he was short MNTA about 3-4 days before approval.

[floblu14]

Most appreciate Dew et al analysis/comments regarding MNTA. At this ridiculous PPS I have had the opportunity to add to the FLO Foundation. Wait for the earnings report via NVS (Oct.21) and then MNTA in early Nov. :-)

Check out some earnings estimates -
http://finance.yahoo.com/q/ae?s=MNTA+Analyst+Estimates

BTW - does anyone have the lovenox/enoxaparin script updates for the last 2 weeks? T.I.A.

[10nisman]

As Wallstarb said the the cash is nice but it won't move the price much unless it goes on for 2+ years. People should have listened to him and not Dew. They would have been much better off.

Let's see... Dew recommended buying MNTA when it was trading around $5-6/share while Wallstarb was short MNTA going into MNTA's FDA Lovenox approval announcement. I'll take my profits from following Dew vs. Wallstarb's shorting loss. How quickly people ignore the real facts.

10nis